Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market
Percutaneous transluminal coronary angioplasty (PTCA) is a minimally invasive procedure to open up blocked coronary arteries, allowing blood to circulate unobstructed to the heart muscle.

The global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, PTCA Balloon accounting for % of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Products global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals and Clinics segment is altered to an % CAGR throughout this forecast period.

China Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market size is valued at US$ million in 2021, while the North America and Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Breakdown Data by Type

PTCA Balloon

PTCA Guide

Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Breakdown Data by Application

Hospitals and Clinics

Ambulatory Surgical Centers

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Boston Scientific

Abbott

Medtronic

Cardinal Health

Asahi Intecc

Terumo

MicroPort

Lepu Medical

Biosensors International

Philips

Yinyi

Wellinq

Teleflex

Sinomed

TABLE OF CONTENT

1 Report Business Overview
1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 PTCA Balloon

1.2.3 PTCA Guide

1.3 Market by Application

1.3.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospitals and Clinics

1.3.3 Ambulatory Surgical Centers

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Perspective (2017-2028)

2.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Growth Trends by Region

2.2.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Historic Market Size by Region (2017-2022)

2.2.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecasted Market Size by Region (2023-2028)

2.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Dynamics

2.3.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Industry Trends

2.3.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Drivers

2.3.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Challenges

2.3.4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Players by Revenue

3.1.1 Global Top Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Players by Revenue (2017-2022)

3.1.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue Market Share by Players (2017-2022)

3.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue

3.4 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Concentration Ratio

3.4.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue in 2021

3.5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Key Players Head office and Area Served

3.6 Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Product Solution and Service

3.7 Date of Enter into Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Breakdown Data by Type

4.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Historic Market Size by Type (2017-2022)

4.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecasted Market Size by Type (2023-2028)

5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Breakdown Data by Application

5.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Historic Market Size by Application (2017-2022)

5.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2017-2028)

6.2 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type

6.2.1 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2017-2022)

6.2.2 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2023-2028)

6.2.3 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Type (2017-2028)

6.3 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application

6.3.1 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2017-2022)

6.3.2 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2023-2028)

6.3.3 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Application (2017-2028)

6.4 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country

6.4.1 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2017-2022)

6.4.2 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2017-2028)

7.2 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type

7.2.1 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2017-2022)

7.2.2 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2023-2028)

7.2.3 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Type (2017-2028)

7.3 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application

7.3.1 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2017-2022)

7.3.2 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2023-2028)

7.3.3 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Application (2017-2028)

7.4 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country

7.4.1 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2017-2022)

7.4.2 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2017-2028)

8.2 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type

8.2.1 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Type (2017-2028)

8.3 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application

8.3.1 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Application (2017-2028)

8.4 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Region

8.4.1 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2017-2028)

9.2 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type

9.2.1 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2017-2022)

9.2.2 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2023-2028)

9.2.3 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Type (2017-2028)

9.3 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application

9.3.1 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2017-2022)

9.3.2 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2023-2028)

9.3.3 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Application (2017-2028)

9.4 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country

9.4.1 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2017-2022)

9.4.2 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2017-2028)

10.2 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type

10.2.1 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Type (2017-2028)

10.3 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application

10.3.1 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Application (2017-2028)

10.4 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country

10.4.1 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Boston Scientific

11.1.1 Boston Scientific Company Details

11.1.2 Boston Scientific Business Overview

11.1.3 Boston Scientific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction

11.1.4 Boston Scientific Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022)

11.1.5 Boston Scientific Recent Developments

11.2 Abbott

11.2.1 Abbott Company Details

11.2.2 Abbott Business Overview

11.2.3 Abbott Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction

11.2.4 Abbott Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022)

11.2.5 Abbott Recent Developments

11.3 Medtronic

11.3.1 Medtronic Company Details

11.3.2 Medtronic Business Overview

11.3.3 Medtronic Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction

11.3.4 Medtronic Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022)

11.3.5 Medtronic Recent Developments

11.4 Cardinal Health

11.4.1 Cardinal Health Company Details

11.4.2 Cardinal Health Business Overview

11.4.3 Cardinal Health Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction

11.4.4 Cardinal Health Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022)

11.4.5 Cardinal Health Recent Developments

11.5 Asahi Intecc

11.5.1 Asahi Intecc Company Details

11.5.2 Asahi Intecc Business Overview

11.5.3 Asahi Intecc Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction

11.5.4 Asahi Intecc Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022)

11.5.5 Asahi Intecc Recent Developments

11.6 Terumo

11.6.1 Terumo Company Details

11.6.2 Terumo Business Overview

11.6.3 Terumo Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction

11.6.4 Terumo Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022)

11.6.5 Terumo Recent Developments

11.7 MicroPort

11.7.1 MicroPort Company Details

11.7.2 MicroPort Business Overview

11.7.3 MicroPort Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction

11.7.4 MicroPort Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022)

11.7.5 MicroPort Recent Developments

11.8 Lepu Medical

11.8.1 Lepu Medical Company Details

11.8.2 Lepu Medical Business Overview

11.8.3 Lepu Medical Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction

11.8.4 Lepu Medical Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022)

11.8.5 Lepu Medical Recent Developments

11.9 Biosensors International

11.9.1 Biosensors International Company Details

11.9.2 Biosensors International Business Overview

11.9.3 Biosensors International Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction

11.9.4 Biosensors International Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022)

11.9.5 Biosensors International Recent Developments

11.10 Philips

11.10.1 Philips Company Details

11.10.2 Philips Business Overview

11.10.3 Philips Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction

11.10.4 Philips Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022)

11.10.5 Philips Recent Developments

11.11 Yinyi

11.11.1 Yinyi Company Details

11.11.2 Yinyi Business Overview

11.11.3 Yinyi Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction

11.11.4 Yinyi Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022)

11.11.5 Yinyi Recent Developments

11.12 Wellinq

11.12.1 Wellinq Company Details

11.12.2 Wellinq Business Overview

11.12.3 Wellinq Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction

11.12.4 Wellinq Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022)

11.12.5 Wellinq Recent Developments

11.13 Teleflex

11.13.1 Teleflex Company Details

11.13.2 Teleflex Business Overview

11.13.3 Teleflex Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction

11.13.4 Teleflex Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022)

11.13.5 Teleflex Recent Developments

11.14 Sinomed

11.14.1 Sinomed Company Details

11.14.2 Sinomed Business Overview

11.14.3 Sinomed Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction

11.14.4 Sinomed Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2017-2022)

11.14.5 Sinomed Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

Delivery Format : EXCEL/Data Pack

Choose License Type

Checkout Inquiry Sample